Insider · CIK 0001793971

Aurora Daljit Singh

Reports to the SEC for 2 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001793971

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+21.1K sh	$0.72	+$15.2K	21,055
2026-08-21	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−21.1K sh	$1.60	−$33.6K	0
2026-08-21	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+20.6K sh	$0.72	+$14.8K	69,303
2026-08-21	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−20.6K sh	—	—	88,974
2026-08-21	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−20.6K sh	$1.59	−$32.8K	48,750
2026-08-21	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−21.1K sh	—	—	94,798
2026-08-20	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−66.7K sh	$1.51	−$101K	0
2026-08-20	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−67.7K sh	—	—	109,527
2026-08-20	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000
2026-08-20	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−67.7K sh	$1.51	−$103K	48,750
2026-08-20	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−21.7K sh	—	—	115,853
2026-08-20	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+67.7K sh	$0.72	+$48.8K	116,491
2026-08-20	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+45K sh	$0.72	+$32.4K	66,711
2026-08-20	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+21.7K sh	$0.72	+$15.6K	21,685
2026-08-20	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−45K sh	—	—	0
2026-08-19	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−30.9K sh	$1.65	−$50.9K	0
2026-08-19	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−17.7K sh	—	—	177,268
2026-08-19	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+30.9K sh	$0.72	+$22.3K	30,918
2026-08-19	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−31K sh	$1.65	−$51K	48,750
2026-08-19	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+17.7K sh	$0.72	+$12.8K	79,750
2026-08-19	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−30.9K sh	—	—	45,026
2026-08-19	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−13.3K sh	—	—	23,367
2026-08-19	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+13.3K sh	$0.72	+$9,552.96	62,018
2026-08-18	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−34.2K sh	—	—	36,635
2026-08-18	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+34.2K sh	$0.72	+$24.6K	82,912
2026-08-18	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+35K sh	$0.72	+$25.2K	34,987
2026-08-18	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−35K sh	—	—	75,944
2026-08-18	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−35K sh	$1.59	−$55.5K	0
2026-08-18	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−34.2K sh	$1.58	−$54.1K	48,750
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−25.3K sh	—	—	110,931
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−29.7K sh	—	—	0
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+25.3K sh	$0.72	+$18.2K	25,279
2026-08-17	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−55K sh	$1.50	−$82.8K	0
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+29.7K sh	$0.72	+$21.4K	55,016
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1 sh	—	—	999,999
2026-08-17	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−34K sh	$1.49	−$50.5K	48,750
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1 sh	$0.72	+$0.72	140,440
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−40.9K sh	—	—	0
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,424 sh	$0.72	+$1,025.28	140,439
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+15.4K sh	$0.72	+$11.1K	139,015
2026-08-17	NMRANeumora Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+40.9K sh	$0.72	+$29.4K	123,660
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−15.4K sh	—	—	192,546
2026-08-17	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1,424 sh	—	—	70,797
2026-08-17	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−57.7K sh	$1.51	−$86.8K	82,770
2026-02-17	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−6,165 sh	$3.56	−$21.9K	82,770
2026-01-08	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+750K sh	—	—	750,000
2025-11-11	NMRANeumora Therapeutics, Inc.S Sale	See Remarks	SSale	−115K sh	$2.68	−$307K	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−1M sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−195K sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−29.7K sh	—	—	0

Recent filings

Accepted (ET)
Aug 214
Aurora Daljit Singh0001610717-26-000385
SEC(opens sec.gov)
Aug 194
Aurora Daljit Singh0001610717-26-000362
SEC(opens sec.gov)

Companies

Address

C/O NEUMORA THERAPEUTICS, INC. 260 ARSENAL PLACE, SUITE 1

WATERTOWN, MA, 02472